Ennis M, Robinson C, Dollery C T
Int Arch Allergy Appl Immunol. 1983;72(4):289-93. doi: 10.1159/000234885.
The action of three compounds reported to elevate intracellular cyclic adenosine monophosphate (cAMP) namely 3-isobutyl-1-methylxanthine (IBMX) and prostaglandins D2 and E1 (PGD2 and PGE1), on histamine release was examined. Three test systems were used: (i) the perfused ovalbumin-sensitized guinea pig lung and (ii) isolated cells from ovalbumin-sensitized guinea pig lung, both of which are IgG-mediated models of anaphylaxis, and (iii) an IgE model of anaphylaxis, using isolated rat peritoneal mast cells from sensitized rats. Both PGD2 and PGE1 were without effect at concentrations likely to be found during anaphylaxis. In contrast, the phosphodiesterase inhibitor, IBMX, was highly active in all three test systems. The role of raised intracellular cAMP levels in the inhibition of histamine release is discussed.
研究了三种据报道可提高细胞内环磷酸腺苷(cAMP)水平的化合物,即3-异丁基-1-甲基黄嘌呤(IBMX)以及前列腺素D2和E1(PGD2和PGE1)对组胺释放的作用。使用了三种测试系统:(i)灌注卵清蛋白致敏豚鼠肺;(ii)来自卵清蛋白致敏豚鼠肺的分离细胞,这两种都是IgG介导的过敏反应模型;以及(iii)使用来自致敏大鼠的分离大鼠腹膜肥大细胞的IgE过敏反应模型。在过敏反应期间可能出现的浓度下,PGD2和PGE1均无作用。相比之下,磷酸二酯酶抑制剂IBMX在所有三种测试系统中都具有高度活性。文中讨论了细胞内cAMP水平升高在抑制组胺释放中的作用。